AAAAAA
Results: 1-25/26
Authors:
Goodwin, DA
Meares, CF
Citation: Da. Goodwin et Cf. Meares, Advances in pretargeting biotechnology, BIOTECH ADV, 19(6), 2001, pp. 435-450
Authors:
DeNardo, GL
DeNardo, SJ
Kukis, DL
O'Donnell, RT
Shen, S
Mirick, GR
Meares, CF
Citation: Gl. Denardo et al., Metabolite production in patients with lymphoma after radiometal-labeled antibody administration, J NUCL MED, 42(9), 2001, pp. 1324-1333
Authors:
Lubic, SP
Goodwin, DA
Meares, CF
Song, C
Osen, M
Hays, M
Citation: Sp. Lubic et al., Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma, J NUCL MED, 42(4), 2001, pp. 670-678
Authors:
Datwyler, SA
Meares, CF
Citation: Sa. Datwyler et Cf. Meares, Artificial iron-dependent proteases, METAL IONS, 38, 2001, pp. 213-254
Authors:
Marr, MT
Datwyler, SA
Meares, CF
Roberts, JW
Citation: Mt. Marr et al., Restructuring of an RNA polymerase holoenzyme elongation complex by lambdoid phage Q proteins, P NAS US, 98(16), 2001, pp. 8972-8978
Authors:
Chmura, AJ
Orton, MS
Meares, CF
Citation: Aj. Chmura et al., Antibodies with infinite affinity, P NAS US, 98(15), 2001, pp. 8480-8484
Authors:
Voss, J
Wu, JH
Hubbell, WL
Jacques, V
Meares, CF
Kaback, HR
Citation: J. Voss et al., Helix packing in the lactose permease of Escherichia coli: Distances between site-directed nitroxides and a lanthanide, BIOCHEM, 40(10), 2001, pp. 3184-3188
Authors:
Wessels, BW
Meares, CF
Citation: Bw. Wessels et Cf. Meares, Physical and chemical properties of radionuclide therapy, SEM RAD ONC, 10(2), 2000, pp. 115-122
Authors:
Corson, DT
Meares, CF
Citation: Dt. Corson et Cf. Meares, Efficient multigram synthesis of the bifunctional chelating agent (S)-1-p-isothiocyanatobenzyl-diethylenetetraminepentaacetic acid, BIOCONJ CHE, 11(2), 2000, pp. 292-299
Authors:
Meares, CF
Citation: Cf. Meares, Editorial: What's new, BIOCONJ CHE, 11(1), 2000, pp. 1-1
Authors:
Datwyler, SA
Meares, CF
Citation: Sa. Datwyler et Cf. Meares, Protein-protein interactions mapped by artificial proteases: where sigma factors bind to RNA polymerase, TRENDS BIOC, 25(9), 2000, pp. 408-414
Authors:
DeNardo, GL
O'Donnell, RT
Shen, S
Kroger, LA
Yuan, AN
Meares, CF
Kukis, DL
DeNardo, SJ
Citation: Gl. Denardo et al., Radiation dosimetry for Y-90-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using In-111-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma, J NUCL MED, 41(5), 2000, pp. 952-958
Authors:
Bown, JA
Kolb, A
Meares, CF
Ishihama, A
Minchin, SD
Busby, SJW
Citation: Ja. Bown et al., Positioning of region 4 of the Escherichia coli RNA polymerase sigma(70) subunit by a transcription activator, J BACT, 182(10), 2000, pp. 2982-2984
Authors:
Fritzberg, AR
Meares, CF
Citation: Ar. Fritzberg et Cf. Meares, Metallic radionuclides for radioimmunotherapy, RADIOIMMUNOTHERAPY OF CANCER, 2000, pp. 57-79
Authors:
Goodwin, DA
Meares, CF
Citation: Da. Goodwin et Cf. Meares, Pretargeted peptide imaging and therapy, CANC BIO R, 14(3), 1999, pp. 145-152
Authors:
DeNardo, GL
Kukis, DL
Shen, S
DeNardo, DA
Meares, CF
DeNardo, SJ
Citation: Gl. Denardo et al., Cu-67- versus I-131-labeled Lym-1 antibody: Comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma, CLIN CANC R, 5(3), 1999, pp. 533-541
Authors:
Peterson, JJ
Meares, CF
Citation: Jj. Peterson et Cf. Meares, Enzymatic cleavage of peptide-linked radiolabels from immunoconjugates, BIOCONJ CHE, 10(4), 1999, pp. 553-557
Authors:
Peterson, JJ
Pak, RH
Meares, CF
Citation: Jj. Peterson et al., Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N ',N '',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy, BIOCONJ CHE, 10(2), 1999, pp. 316-320
Authors:
Mirick, GR
O'Donnell, RT
DeNardo, SJ
Shen, S
Meares, CF
DeNardo, GL
Citation: Gr. Mirick et al., Transfer of copper from a chelated Cu-67-antibody conjugate to ceruloplasmin in lymphoma patients, NUCL MED BI, 26(7), 1999, pp. 841-845
Authors:
Colland, F
Fujita, N
Kotlarz, D
Bown, JA
Meares, CF
Ishihama, A
Kolb, A
Citation: F. Colland et al., Positioning of sigma(S), the stationary phase sigma factor, in Escherichiacoli RNA polymerase-promoter open complexes, EMBO J, 18(14), 1999, pp. 4049-4059
Authors:
Rose, LM
Deng, CT
Scott, SL
Xiong, CY
Lamborn, KR
Gumerlock, PH
DeNardo, GL
Meares, CF
Citation: Lm. Rose et al., Critical Lym-1 binding residues on polymorphic HLA-DR molecules, MOL IMMUNOL, 36(11-12), 1999, pp. 789-797
Authors:
Bown, JA
Owens, JT
Meares, CF
Fujita, N
Ishihama, A
Busby, SJW
Minchin, SD
Citation: Ja. Bown et al., Organization of open complexes at Escherichia coli promoters - Location ofpromoter DNA sites close to region 2.5 of the sigma(70) subunit of RNA polymerase, J BIOL CHEM, 274(4), 1999, pp. 2263-2270
Authors:
Traviglia, SL
Datwyler, SA
Yan, DL
Ishihama, A
Meares, CF
Citation: Sl. Traviglia et al., Targeted protein footprinting: Where different transcription factors bind to RNA polymerase, BIOCHEM, 38(48), 1999, pp. 15774-15778
Authors:
Traviglia, SL
Datwyler, SA
Meares, CF
Citation: Sl. Traviglia et al., Mapping protein-protein interactions with a library of tethered cutting reagents: The binding site of sigma(70) on Escherichia coli RNA polymerase, BIOCHEM, 38(14), 1999, pp. 4259-4265
Authors:
Miyake, R
Owens, JT
Xu, DD
Jackson, WM
Meares, CF
Citation: R. Miyake et al., Site-directed photocleavage for mapping protein architecture, J AM CHEM S, 121(32), 1999, pp. 7453-7454